A third dose SARS‑CoV‑2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients

BACKGROUND: The hemodialysis (HD) population has been a vulnerable group during the coronavirus disease 2019 (COVID-19) pandemic. Advanced chronic kidney disease with uremia is associated with weaker immune response to infections and an attenuated response to vaccines. The aim of this study was to s...

Descripción completa

Detalles Bibliográficos
Autores principales: Melin, Jan, Svensson, Maria K, Albinsson, Bo, Winqvist, Ola, Pauksens, Karlis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Academia 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602199/
https://www.ncbi.nlm.nih.gov/pubmed/36337280
http://dx.doi.org/10.48101/ujms.v127.8959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602199/
https://www.ncbi.nlm.nih.gov/pubmed/36337280
http://dx.doi.org/10.48101/ujms.v127.8959

Ejemplares similares